Nomura Asset Management CO LTD Chemo Centryx, Inc. Transaction History

Nomura Asset Management CO LTD

$31.8 Billion
Q3 2024

Shares

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2022 Aug 12, 2022	BUY	$15.36 - $27.51 $0 - $0	0 New	0 $0
Q1 2022 May 13, 2022	BUY	$22.22 - $39.12 $0 - $0	0 New	0 $0
Q4 2021 Feb 01, 2022	BUY	$18.38 - $40.5 $0 - $0	0 New	0 $0
Q2 2021 Aug 06, 2021	SELL	$9.59 - $50.88 $0 - $0	0 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$49.53 - $68.4 $0 - $0	0 New	0 $0
Q4 2020 Feb 12, 2021	BUY	$47.25 - $65.16 $0 - $0	0 New	0 $0
Q3 2020 Nov 12, 2020	BUY	$46.35 - $61.69 $0 - $0	0 New	0 $0
Q2 2020 Aug 13, 2020	BUY	$38.58 - $65.07 $0 - $0	0 New	0 $0
Q1 2020 May 14, 2020	BUY	$32.73 - $50.78 $0 - $0	0 New	0 $0

Others Institutions Holding CCXI

# of Institutions

6

Shares Held

66.3K

Call Options Held

0

Put Options Held

0

About ChemoCentryx, Inc.

Ticker CCXI
Exchange NASDAQ
Shares Outstandng 71,919,696
Market Cap $3.68M
Description
ChemoCentryx, Inc., a biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. It offers TAVNEOS (avacopan), an orally administered selective C5aR inhibitor for the treatment of adult patients with severe active anti-neutrophil...

More about CCXI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nomura Asset Management CO LTD, based on Form 13F filings with the SEC.

News

Stay updated on Nomura Asset Management CO LTD with notifications on news.